Sign in
Not yet recruitingNo phase

Two types of laser treatment for trigeminal neuralgia pain compared

Compares two laser treatments for facial nerve pain in adults with trigeminal neuralgia.

Key facts

Who runs it
Alexandria University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
High-intensity Laser Therapy Versus Low Level Laser Therapy in the Treatment of Trigeminal Neuralgia
Status
Not yet recruiting
People taking part
38 people, planned
Started
15 May 2026
Expected to end
30 Dec 2026
Type of study
Interventional, 2 groups
Treatments tested
  • 1064 nm Nd-YAG Laser
  • 940 nm Diode laser
Record updated
15 May 2026

Who can take part

The trial is looking for adults with trigeminal neuralgia, a severe facial nerve pain, that has not improved with medicines. It compares two types of laser treatment.

Age
18 Years and older
Sex
All
Disease stage
Trigeminal neuralgia diagnosed by the ICHD-3 criteria. Pain must not respond to medicines (drug refractory).
Earlier treatment
Poor response to adequate medicines, or side effects too hard to bear, for at least three months. People must be unable to have surgery or other procedures, or have had them without enough pain relief.
Main reasons for not taking part
  • Trigeminal neuralgia caused by a brain lesion that needs surgery
  • Other face or jaw conditions, migraine, or other nerve diseases
  • Reasons laser cannot be used, such as a pacemaker
  • Responding well to medical treatment
  • Pregnant or breastfeeding women
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Patients diagnosed with trigeminal neuralgia according to the International Classification of Headache Disorders (ICHD-3) diagnostic criteria
  • Patients with drug refractory trigeminal neuralgia (defined as poor response to adequate pharmacological treatment or intolerance to side effects for at least three months)
  • Patients who are contraindicated for surgical intervention or any other interventions, or who have previously undergone such interventions without obtaining satisfactory pain relief

Who cannot take part

  • patients with secondary trigeminal neuralgia diagnosed with brain lesions that is indicated for surgery (percutaneous procedures, gamma knife, microvascular decompression)
  • Patients with other orofacial conditions such as temporomandibular disorders, migraine, or other neurological diseases
  • Patients with contraindications to laser use (e.g., pacemakers)
  • Patients who are responding well to medical treatment
  • Pregnant or lactating women

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Trigeminal neuralgia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Trigeminal neuralgia (TN) is the most common and severe type of neuropathic pain disorder affecting the orofacial region. It is characterized by sudden, intense, episodic attacks of pain in the distribution of trigeminal nerve, usually unilateral. The condition severely impairs patient's quality of life. TN represents a diagnostic and therapeutic challenge, pharmacological therapy remains the first-line management, and many patients experience reduced drug tolerance or significant side effects over time. Surgical options are considered for refractory cases but are invasive and carry risks such as infection, nerve damage, and recurrence of symptoms. In recent years, laser based therapies have gained attention as safe, non-invasive alternatives. Low level laser therapy (LLLT) promotes photo-biomodulation and nerve repair without thermal damage, while high-intensity laser therapy (HILT) can achieve deeper penetration and direct neuromodulation. However, comparative evidence regarding their efficacy in TN is still limited. Aim: The present study aims to evaluate and compare the effect of High intensity laser therapy and low level laser therapy in reducing pain intensity and improving quality of life in patients with trigeminal neuralgia.

The 2 groups in the trial

  • Nd-YAG LaserTreatment being tested

    Treatment: 1064 nm Nd-YAG Laser

  • Diode laserTreatment being tested

    Treatment: 940 nm Diode laser

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
High-intensity Laser Therapy Versus Low Level Laser Therapy in the Treatment of Trigeminal Neuralgia (a Randomized Clinical Trial)
Plain-language title
Two types of laser treatment for trigeminal neuralgia pain comparedGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT07590414, who can take part
Record updated
15 May 2026